MAI Capital Management

Position in HLN — Haleon plc

CIK 1040197 INDEPENDENCE, OH

Position in HLN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$274,422

+$77,406 QoQ

Shares Held

29,413

+49.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#244

of 642 holders

Holding Since

Sep 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

MAI Capital Management holds $5,871,377 across 11 Drug Manufacturers - Specialty & Generic names. HLN ranks #6 (4.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	24,462	$1,757,838
2	NBIX	Neurocrine Biosciences Inc	8,096	$1,364,498
3	UTHR	UNITED THERAPEUTICS Corp	1,934	$1,047,898
4	VTRS	Viatris Inc	32,111	$509,922
5	TEVA	Teva Pharmaceutical Industries Ltd	8,901	$301,565
6	HLN	Haleon plc This page	29,413	$274,422
7	ANIP	Ani Pharmaceuticals Inc	2,683	$222,098
8	TAK	Takeda Pharmaceutical Co Ltd	10,292	$164,979

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$274,422	29,413	+49.4%	Shares	Defined	2026-08-14
2026-03-31	$197,016	19,682	+7.4%	Shares	Sole	2026-05-15
2025-12-31	$185,194	18,318	+0.9%	Shares	Sole	2026-02-13
2025-09-30	$162,814	18,151	-13.4%	Shares	Sole	2025-11-10
2025-06-30	$217,313	20,956	+40.2%	Shares	Sole	2025-08-12
2025-03-31	$153,763	14,943	-31.2%	Shares	Sole	2025-05-15
2024-12-31	$207,227	21,722	-33.2%	Shares	Sole	2025-02-14
2024-09-30	$343,945	32,509	-1.5%	Shares	Sole	2024-11-07
2024-06-30	$272,604	33,003	+16.2%	Shares	Sole	2024-08-12
2024-03-31	$241,056	28,393	+18.0%	Shares	Sole	2024-05-08
2023-12-31	$197,956	24,053	+13.3%	Shares	Sole	2024-02-09
2023-09-30	$176,812	21,226	+34.1%	Shares	Sole	2023-11-14
2023-03-31	$128,880	15,833	+44.8%	Shares	Sole	2023-05-10
2022-12-31	$87,480	10,935	-21.4%	Shares	Sole	2023-02-09
2022-09-30	$84,772	13,920	—	Shares	Sole	2022-11-15
No filing history on record for this holder in this stock.